Tesla
TSLA
Apple
AAPL
Meta Platforms
META
Microsoft
MSFT
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
BIOA BioAge Labs
- 4.490
- +0.110+2.51%
Close Mar 21 16:00 ET
- 4.490
- 0.0000.00%
Post 20:01 ET
160.97MMarket Cap-2.26P/E (TTM)
4.570High4.240Low115.82KVolume4.240Open4.380Pre Close514.67KTurnover1.10%Turnover RatioLossP/E (Static)35.85MShares26.62052wk High0.50P/B47.15MFloat Cap3.85052wk Low--Dividend TTM10.50MShs Float26.620Historical High--Div YieldTTM7.53%Amplitude3.850Historical Low4.443Avg Price1Lot Size
BioAge Labs Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -37.90%-51.52M | 39.57%-5.14M | -92.34%-14.93M | -42.24%-15.78M | -56.70%-15.67M | -3.26%-37.36M | -8.5M | -7.76M | -11.1M | -10M |
| Net income from continuing operations | -11.36%-71.11M | -0.82%-21.13M | -60.05%-23.41M | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | ---20.96M | ---14.63M | ---17.19M | ---11.08M |
| Operating gains losses | -97.70%232K | -107.76%-402K | -89.21%306K | -96.59%70K | 1,128.57%258K | 43,973.91%10.09M | --5.18M | --2.84M | --2.05M | --21K |
| Depreciation and amortization | 3.09%167K | 14.63%47K | -20.83%38K | 22.50%49K | 0.00%33K | 25.58%162K | --41K | --48K | --40K | --33K |
| Other non cash items | -84.14%1.03M | -97.78%43K | -97.26%53K | -97.01%60K | 37.03%877K | 6,413.00%6.51M | --1.94M | --1.93M | --2M | --640K |
| Change In working capital | 66.56%11.18M | 199.96%13.58M | 382.65%6.23M | -418.53%-3.94M | -1,262.32%-4.7M | 744.03%6.71M | --4.53M | --1.29M | --1.24M | ---345K |
| -Change in prepaid assets | -6,600.00%-2.41M | -518.13%-761K | -127.38%-23K | -87.91%-684K | -794.07%-937K | 223.33%37K | --182K | --84K | ---364K | --135K |
| -Change in payables and accrued expense | 38.95%4.63M | -51.79%2.08M | 553.09%9.54M | -301.75%-3.23M | -683.96%-3.76M | 605.07%3.34M | --4.32M | ---2.11M | --1.6M | ---480K |
| -Change in other current assets | -1,060.00%-240K | ---- | ---- | ---- | ---- | -92.90%25K | ---- | ---- | ---- | ---- |
| -Change in other working capital | 177.30%9.19M | --12.5M | ---- | ---- | ---- | --3.31M | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -37.90%-51.52M | 39.57%-5.14M | -92.34%-14.93M | -42.24%-15.78M | -56.70%-15.67M | -3.26%-37.36M | ---8.5M | ---7.76M | ---11.1M | ---10M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -37.59%-366K | -26K | -208.08%-305K | 37.50%-35K | 0 | -158.25%-266K | 0 | -99K | -56K | -111K |
| Net PPE purchase and sale | -120.48%-366K | ---26K | -208.08%-305K | 37.50%-35K | --0 | -61.17%-166K | --0 | ---99K | ---56K | ---11K |
| Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | ---100K | --0 | --0 | --0 | ---100K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -37.59%-366K | ---26K | -208.08%-305K | 37.50%-35K | --0 | -158.25%-266K | --0 | ---99K | ---56K | ---111K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 990.98%381.2M | 2,567.99%24.9M | 454,107.14%190.68M | -119.10%-2.39M | 615.02%168M | 1,298.20%34.94M | -1.01M | -42K | 12.5M | 23.5M |
| Net issuance payments of debt | -117.14%-6M | -50.00%-1.5M | ---1.5M | -112.00%-1.5M | -106.38%-1.5M | 1,300.00%35M | ---1M | --0 | --12.5M | --23.5M |
| Net common stock issuance | --221.62M | --27.62M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net preferred stock issuance | --170M | --0 | --542K | ---40K | --169.5M | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 15,750.00%634K | 525.00%25K | --184K | --422K | --3K | -90.91%4K | --4K | --0 | --0 | --0 |
| Net other financing activities | -7,922.22%-5.05M | -9,469.23%-1.24M | -5,950.00%-2.54M | ---- | ---- | -40.00%-63K | ---13K | ---42K | ---4K | ---4K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 990.98%381.2M | 2,567.99%24.9M | 454,107.14%190.68M | -119.10%-2.39M | 615.02%168M | 1,298.20%34.94M | ---1.01M | ---42K | --12.5M | --23.5M |
| Net cash flow | ||||||||||
| Beginning cash position | -9.72%24.96M | 868.54%334.47M | 275.17%159.09M | 332.28%177.31M | -9.72%24.96M | -54.82%27.64M | --34.53M | --42.4M | --41.02M | --27.64M |
| Current changes in cash | 12,355.71%329.31M | 307.51%19.74M | 2,319.72%175.45M | -1,453.38%-18.2M | 1,038.14%152.33M | 92.05%-2.69M | ---9.51M | ---7.9M | --1.35M | --13.38M |
| Effect of exchange rate changes | --81K | 310.77%137K | -265.71%-58K | -140.48%-17K | 258.33%19K | --0 | ---65K | --35K | --42K | ---12K |
| End cash Position | 1,319.84%354.35M | 1,319.84%354.35M | 868.54%334.47M | 275.17%159.09M | 332.28%177.31M | -9.72%24.96M | --24.96M | --34.53M | --42.4M | --41.02M |
| Free cash flow | -38.26%-51.89M | 39.27%-5.16M | -93.79%-15.24M | -41.83%-15.82M | -56.53%-15.67M | -3.43%-37.53M | ---8.5M | ---7.86M | ---11.15M | ---10.01M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
